scholarly journals Opioid Prescribing Patterns and Patient Outcomes by Prescriber Type in the Oregon Prescription Drug Monitoring Program

Pain Medicine ◽  
2017 ◽  
Vol 19 (12) ◽  
pp. 2481-2486 ◽  
Author(s):  
Patrick B Fink ◽  
Richard A Deyo ◽  
Sara E Hallvik ◽  
Christi Hildebran
Keyword(s):  
Prescription Drug ◽  
Patient Outcomes ◽  
Drug Monitoring ◽  
Monitoring Program ◽  
Prescribing Patterns ◽  
Opioid Prescribing ◽  
Prescription Drug Monitoring Program

The effect of a statewide prescription drug monitoring program on opioid prescribing patterns

2021 ◽  
pp. 103262
Author(s):  
Samuel J. Rubin ◽  
Judy J. Wang ◽  
Ariana Y. Nodoushani ◽  
Bharat B. Yarlagadda ◽  
Jacqueline A. Wulu ◽  
...  
Keyword(s):  
Prescription Drug ◽  
Drug Monitoring ◽  
Monitoring Program ◽  
Prescribing Patterns ◽  
Opioid Prescribing ◽  
Prescription Drug Monitoring Program

scholarly journals Prescription Drug Monitoring Program Mandates: Impact On Opioid Prescribing And Related Hospital Use

2019 ◽  
Vol 38 (9) ◽  
pp. 1550-1556 ◽  
Author(s):  
Hefei Wen ◽  
Jason M. Hockenberry ◽  
Philip J. Jeng ◽  
Yuhua Bao
Keyword(s):  
Prescription Drug ◽  
Drug Monitoring ◽  
Monitoring Program ◽  
Opioid Prescribing ◽  
Prescription Drug Monitoring Program ◽  
Hospital Use

scholarly journals Effect of Florida’s Prescription Drug Monitoring Program and Pill Mill Laws on Opioid Prescribing and Use

2015 ◽  
Vol 175 (10) ◽  
pp. 1642 ◽  
Author(s):  
Lainie Rutkow ◽  
Hsien-Yen Chang ◽  
Matthew Daubresse ◽  
Daniel W. Webster ◽  
Elizabeth A. Stuart ◽  
...  
Keyword(s):  
Prescription Drug ◽  
Drug Monitoring ◽  
Monitoring Program ◽  
Opioid Prescribing ◽  
Prescription Drug Monitoring Program

scholarly journals Changes in opioid prescribing after implementation of mandatory registration and proactive reports within California’s prescription drug monitoring program

2021 ◽  
Vol 218 ◽  
pp. 108405
Author(s):  
Alvaro Castillo-Carniglia ◽  
Andrés González-Santa Cruz ◽  
Magdalena Cerdá ◽  
Chris Delcher ◽  
Aaron B. Shev ◽  
...  
Keyword(s):  
Prescription Drug ◽  
Drug Monitoring ◽  
Monitoring Program ◽  
Opioid Prescribing ◽  
Prescription Drug Monitoring Program

scholarly journals The Pennsylvania Prescription Drug Monitoring Program: Reducing the Misuse of Prescription Opioids

Commonwealth ◽  
2018 ◽  
Vol 20 (2-3) ◽  
Author(s):  
Lynn S. Mirigian ◽  
Laura A. Hendrick ◽  
Janice L. Pringle ◽  
Michael A. Zemaitis
Keyword(s):  
Prescription Drug ◽  
Drug Monitoring ◽  
Monitoring Program ◽  
Opioid Use Disorder ◽  
Prescribing Patterns ◽  
Opioid Overdose ◽  
Opioid Use ◽  
University Of Pittsburgh ◽  
Drug Enforcement Administration ◽  
Prescription Drug Monitoring Program

In 2016, 4,642 Pennsylvanians died from a drug overdose and 85% of these deaths were due to an opioid overdose (U.S. Drug Enforcement Administration and University of Pittsburgh School of Pharmacy 2017). With a 37% increase in deaths from 2015, the Commonwealth’s response to this epidemic has come from several fronts. One valuable resource has been the modernization and implementation of Pennsylvania’s Prescription Drug Monitoring Program (PDMP). PDMPs are state-­run programs that record dispensing of most controlled substances and provide this data to physicians and pharmacists (among others) to inform their practice about possible opioid use disorder by a given patient. This article discusses the role of Pennsylvania’s PDMP in patient care and law enforcement to reduce opioid overdoses in the Commonwealth. Recent evidence is discussed that demonstrates the effectiveness of state-­run PDMPs and their impact on opioid misuse and prescribing patterns. It is important to note that additional research into the effectiveness of PDMPs in preventing opioid-­related morbidity and mortality is needed.

scholarly journals Mandatory Review of Prescription Drug Monitoring Program Before Issuance of a Controlled Substance Results in Overall Reduction of Prescriptions Including Opioids and Benzodiazepines

2020 ◽  
Vol 3;23 (6;3) ◽  
pp. 299-304
Author(s):  
Alaa Abd-Elsayed
Keyword(s):  
Prescription Drug ◽  
Drug Monitoring ◽  
Monitoring Program ◽  
The United States ◽  
The State ◽  
Prescribing Patterns ◽  
P Value ◽  
Prescription Drug Monitoring Program ◽  
Before And After ◽  
Controlled Substance

Background: To date, there is limited research on whether the various types of mandatory usage of prescription drug monitoring programs (PDMP) have any effects on prescribing patterns, drug usage, patient care, and drug diversion (8-10). Within the United States (US), there is wide variation in individual states’ requirements for the usage of PDMPs. Objective: The objective of this study was to determine whether mandatory prescriber review of a PDMP prior to each issuance of a controlled substance resulted in a reduction in the total number of controlled substance prescriptions dispensed. Study Design: A retrospective review of the State of Wisconsin’s PDMP controlled substance database from April 2015 to March 2019 was performed. The evaluation compared the number of prescriptions among individual drug classes (opioids, benzodiazepines, stimulants) dispensed throughout the state before and after April 1st, 2017, when implementation of a state law mandating the review of the PDMP during each patient encounter prior to issuing a prescription for a controlled substance took effect. Setting: Research was conducted using Wisconsin’s PDMP controlled substance database from April 2015 to March 2019. During this time, controlled substance policy has come to the forefront of the nation due to issues with an opioid epidemic. Methods: Descriptive analysis was used to express data as n and % for categorical data and average ± standard deviation for numerical data. Before- and after-prescription totals were analyzed using a paired t test and Levene’s test for equality of variances. The P value was considered significant at a level ≤ .05. Limitations: Limitations to this study included its retrospective design, focus on a single US state, and possible unforeseen contributors to cause and effect. Results: Prior to the enforcement of the state’s mandatory PDMP legislation, an average of 844,314 controlled substance prescriptions were written monthly. Following the implementation of the law, the average monthly total prescriptions written within the state decreased to 708,063. This was an average monthly reduction of 136,251 prescriptions written or 16.1%. Statistically significant reductions were also seen in opioid and benzodiazepine subgroups (23.0%, 16.3%). Conclusion: Our study suggests that state-enforced mandatory usage of a PDMP, which records all controlled substance prescriptions filled by a pharmacy such as opioids, benzodiazepines, amphetamines, etc. at every encounter prior to prescribing any controlled substance, can provide for a significant reduction in controlled substance prescriptions, specifically opioids and benzodiazepines. Key words: Prescription drug monitoring program, opioids, mandatory usage, benzodiazepines, Wisconsin

Sign in / Sign up

Export Citation Format

Share Document